news July 11, 2023

Rend Al-Mondhiry Quoted in “FDA, Industry Preaching Opposing CBD Narratives on Capitol Hill”

Rend Al-Mondhiry spoke with Josh Long, Natural Products Insider, about the conflicting narratives lawmakers are hearing from the FDA and hemp industry stakeholders on the safety of CBD.

Rend stated, “It doesn’t seem like all of this information in its totality is being considered in these conclusions that the FDA is making.”

Read more on the subject in the full story here.